What is the underlying defect in patients with atopic dermatitis? At least 50% of patients with moderate to severe atopic dermatitis have a defect in the gene coding for filaggrin, a protein essential to maintaining the barrier function of the stratum corneum. The stratum corneum then allows various irritants, microbes, or allergens to penetrate the skin surface, elicit cytokine release from keratinocytes, and initiate a Th2 immune response acutely that leads to the clinical manifestations of disease and increased IgE levels. In chronic cases of atopic dermatitis, the Th2 response is replaced by a Th1 response. A primary immune defect, at least in some atopic patients, cannot yet be ruled out because bone marrow stem cell transplants from atopic patients have transferred atopic dermatitis to recipients. Terui T: Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: overview of the pathophysiology of atopic dermatitis, J Pharmacol Sci 110:232–236, 2009. |
© 2024 Skin Disease & Care | All Rights Reserved.